BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 11971978)

  • 1. Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2.
    Ancelin K; Brunori M; Bauwens S; Koering CE; Brun C; Ricoul M; Pommier JP; Sabatier L; Gilson E
    Mol Cell Biol; 2002 May; 22(10):3474-87. PubMed ID: 11971978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Telomere Repeat Binding Factor TRF1 Replaces TRF2 Bound to Shelterin Core Hub TIN2 when TPP1 Is Absent.
    Janovič T; Stojaspal M; Veverka P; Horáková D; Hofr C
    J Mol Biol; 2019 Aug; 431(17):3289-3301. PubMed ID: 31158366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.
    Butler KS; Hines WC; Heaphy CM; Griffith JK
    Cancer Med; 2012 Oct; 1(2):165-75. PubMed ID: 23342266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRF2 recruits ORC through TRFH domain dimerization.
    Higa M; Kushiyama T; Kurashige S; Kohmon D; Enokitani K; Iwahori S; Sugimoto N; Yoshida K; Fujita M
    Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):191-201. PubMed ID: 27836746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Super-telomeres in transformed human fibroblasts.
    Chiodi I; Belgiovine C; Zongaro S; Ricotti R; Horard B; Lossani A; Focher F; Gilson E; Giulotto E; Mondello C
    Biochim Biophys Acta; 2013 Aug; 1833(8):1885-93. PubMed ID: 23570868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere shortening and expression of TRF1 and TRF2 in uterine leiomyoma.
    Oh BK; Choi Y; Choi JS
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere length modulation in human astroglial brain tumors.
    La Torre D; Conti A; Aguennouz MH; De Pasquale MG; Romeo S; Angileri FF; Cardali S; Tomasello C; Alafaci C; Germanò A
    PLoS One; 2013; 8(5):e64296. PubMed ID: 23691191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZSCAN4 and TRF1: A functionally indirect interaction in cancer cells independent of telomerase activity.
    Lee K; Gollahon LS
    Biochem Biophys Res Commun; 2015 Oct; 466(4):644-9. PubMed ID: 26403970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncoding telomeric repeat-containing RNA inhibits the progression of hepatocellular carcinoma by regulating telomerase-mediated telomere length.
    Cao H; Zhai Y; Ji X; Wang Y; Zhao J; Xing J; An J; Ren T
    Cancer Sci; 2020 Aug; 111(8):2789-2802. PubMed ID: 32357278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase inhibitor PinX1 provides a link between TRF1 and telomerase to prevent telomere elongation.
    Soohoo CY; Shi R; Lee TH; Huang P; Lu KP; Zhou XZ
    J Biol Chem; 2011 Feb; 286(5):3894-906. PubMed ID: 21119197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-PKcs-interacting protein KIP binding to TRF2 is required for the maintenance of functional telomeres.
    Khadka P; Lee JH; Baek SH; Oh SY; Chung IK
    Biochem J; 2014 Oct; 463(1):19-30. PubMed ID: 25012820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-translational modifications of TRF1 and TRF2 and their roles in telomere maintenance.
    Walker JR; Zhu XD
    Mech Ageing Dev; 2012 Jun; 133(6):421-34. PubMed ID: 22634377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcusone C induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2.
    Wang M; Cao J; Zhu JY; Qiu J; Zhang Y; Shu B; Ou TM; Tan JH; Gu LQ; Huang ZS; Yin S; Li D
    Biochim Biophys Acta Proteins Proteom; 2017 Nov; 1865(11 Pt A):1372-1382. PubMed ID: 28870734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRF1 participates in chromosome end protection by averting TRF2-dependent telomeric R loops.
    Lee YW; Arora R; Wischnewski H; Azzalin CM
    Nat Struct Mol Biol; 2018 Feb; 25(2):147-153. PubMed ID: 29358759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression for suppressors of telomerase activity (telomeric-repeat binding factors) in breast cancer.
    Saito K; Yagihashi A; Nasu S; Izawa Y; Nakamura M; Kobayashi D; Tsuji N; Watanabe N
    Jpn J Cancer Res; 2002 Mar; 93(3):253-8. PubMed ID: 11927006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRF1 and TRF2 binding to telomeres is modulated by nucleosomal organization.
    Galati A; Micheli E; Alicata C; Ingegnere T; Cicconi A; Pusch MC; Giraud-Panis MJ; Gilson E; Cacchione S
    Nucleic Acids Res; 2015 Jul; 43(12):5824-37. PubMed ID: 25999344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TZAP: A telomere-associated protein involved in telomere length control.
    Li JS; Miralles Fusté J; Simavorian T; Bartocci C; Tsai J; Karlseder J; Lazzerini Denchi E
    Science; 2017 Feb; 355(6325):638-641. PubMed ID: 28082411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent telomere cohesion protects aged cells from premature senescence.
    Azarm K; Bhardwaj A; Kim E; Smith S
    Nat Commun; 2020 Jul; 11(1):3321. PubMed ID: 32620872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRF1 phosphorylation on T271 modulates telomerase-dependent telomere length maintenance as well as the formation of ALT-associated PML bodies.
    Ho A; Wilson FR; Peragine SL; Jeyanthan K; Mitchell TR; Zhu XD
    Sci Rep; 2016 Nov; 6():36913. PubMed ID: 27841304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere dysfunction and activation of alternative lengthening of telomeres in B-lymphocytes infected by Epstein-Barr virus.
    Kamranvar SA; Chen X; Masucci MG
    Oncogene; 2013 Dec; 32(49):5522-30. PubMed ID: 23708666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.